Industry: Drug Manufacturing, Pharmaceuticals, Biotechnology
D-Pharm (www.dpharm.com) is a clinical-stage biopharmaceutical company pioneering the development of Lipid-Like Therapeutics. D-Pharm is engaged in both drug targeting and drug discovery based on the Company’s technological platforms: (i) Regulated Activation of Prodrugs (D-RAP(TM)); (ii) Membrane Activated Chelators (MAC); and (iii) LipidoMimetix(TM). This has enabled the Company to generate a rich pipeline of innovative drugs for the treatment of CNS disorders, cancer, and autoimmune diseases. The company’s business strategy is to develop its products through “proof of principle in man” and to seek partners for advanced clinical development and commercialization. D-RAP(TM) and LipidoMimetix(TM) are trademarks of D-Pharm Limited. ( www.dpharm.com )
D-Pharm Ltd.
47 Hulfish Street Suite 310
Princeton, New Jersey 08642
USA
Tel: (609) 683-8300
Fax: (609) 683-5787